Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07664527
PHASE4

Novel Method for Removal of Orally Deposited Inhaled Fluticasone Propionate

Sponsor: University of Wisconsin, Madison

View on ClinicalTrials.gov

Summary

This study is to find out if an Extra Virgin Olive-Oil-based Water (EVOOW) mix, removes more Fluticasone Propionate (FP) from the mouth than Water alone. 2 strengths of the EVOOW mix will be tested, one with equal parts EVOO and Water (50/50) and one with 3 parts EVOO and 1 part Water (75/25). Removing more FP deposits may help decrease the risk for obstructive sleep apnea (OSA), candidiasis (thrush), and speech and swallow dysfunction. Participants will be on study for up to 3 weeks.

Official title: A Proof-of-Concept Study of a Novel Method for Removal of Residual Oropharyngeal Inhaled Corticosteroid Deposits in Asthma

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-06

Completion Date

2027-04

Last Updated

2026-06-24

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Fluticasone Propionate

Participants will be administered 1 puff of 220 micrograms FP, via Metered Dose Inhaler, without inhaling into the lungs.

OTHER

Water Mouthwash

Participants will rinse and gargle with 3 consecutive aliquots (20ml each) of either Water (W).

OTHER

EVOOW Mouthwash

Participants will rinse and gargle with 3 consecutive aliquots (20 ml each) of an equal parts EVOO and Water mixture.

Locations (1)

University of Wisconsin

Madison, Wisconsin, United States